Rare disease treatments skipping UK patients largely due to costs, survey shows
A survey has shown that pharma companies have low confidence their rare disease medicines can launch in the UK.
A survey has shown that pharma companies have low confidence their rare disease medicines can launch in the UK.
What's Your Reaction?
